AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glywohn M 2mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Riyadh Pharmaceutical

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glywohn M 2mg/500mg Tablet

Diabexe Duo 2mg/500mg tablets are classified as antidiabetic medications, combining two active ingredients to manage type 2 diabetes in adults. This medication helps regulate blood glucose levels. Diabexe Duo should be administered with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continue taking this medication even with well-controlled blood sugar, as discontinuation without medical supervision risks elevated blood glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is part of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. The most frequent adverse effect is hypoglycemia (low blood sugar). Learn to recognize its symptoms—sweating, dizziness, headache, tremors—and how to treat it. Regular meals and readily available glucose sources (sugary foods or juice) are crucial. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Individuals with a history of heart disease should inform their physician before starting treatment. Pregnant or breastfeeding women should consult their doctor before use. Regular blood glucose monitoring is necessary, and your doctor might recommend blood tests to track blood cell counts and liver function.

Uses of Glywohn M 2mg/500mg Tablet

Managing Type 2 Diabetes

Major Benefits of Glywohn M 2mg/500mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the Glywohn M 2mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with food.

Common Side effects of Glywohn M 2mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glywohn M 2mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glywohn M 2mg/500mg Tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. Administer this medication with food.

How Glywohn M 2mg/500mg Tablet works:

Glywohn M 2mg/500mg tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, enhances insulin secretion from the pancreas, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Glywohn M 2mg/500mg tablets is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glywohn M 2mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to a fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation is contraindicated with Glywohn M 2mg/500mg Tablets due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Glywohn M 2mg/500mg tablets cautiously, potentially requiring dosage modification under medical supervision. This medication is contraindicated in patients with severely compromised kidney function. Regular monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glywohn M 2mg/500mg tablets cautiously, potentially requiring dosage modification. Individuals with mild to moderate hepatic dysfunction may begin with a reduced Glywohn M 2mg/500mg tablet dose; however, its use is contraindicated in those with severe liver disease. Physician consultation is advised.

What if you forget to take Glywohn M 2mg/500mg Tablet :

Should you forget a Glywohn M 2mg/500mg Tablet dose, take it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual regimen. Avoid taking a double dose.

Facts to Know About Glywohn M 2mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Medication

FAQs on Glywohn M 2mg/500mg Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it remains inaccessible to children, pets, and others.
Glywohn M 2mg/500mg Tablets can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Glywohn M 2mg/500mg Tablets and seek immediate medical attention.
Glywohn M 2mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is not suitable for type 1 DM.
Glywohn M 2mg/500mg tablets may cause common side effects such as low blood sugar, taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged Glywohn M 2mg/500mg Tablet use can lead to Vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance issues), urinary problems, and cognitive changes. To mitigate these risks, annual supplemental Vitamin B12 is recommended by some researchers.
Glywohn M 2mg/500mg Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glywohn M 2mg/500mg tablets with alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia) and increased lactic acidosis.
Glywohn M 2mg/500mg Table...
57
MRP 70
17% off